Potential supervisors and their fields of research are featured below.
Dr Ryan Courtney: email@example.com
Smoking cessation; tobacco smoking in low socio-economic status (SES) and disadvantaged populations; socio-economic inequalities and health behaviours and outcomes.
Professor Louisa Degenhardt: firstname.lastname@example.org
Epidemiology of illicit drug use (especially cannabis, amphetamines, cocaine and heroin); mortality among illicit drug users; drug use among young people; crime among heroin dependent people; injecting drug use; pharmaceutical opioid use, including by people who are living with chronic pain.
Dr Natasa Gisev: email@example.com
Pharmaceutical opioid use and related harms; maximising treatment outcomes for people with opioid dependence, including those with co-morbid mental health disorders; quality use of opioids and psychotropic medicines, including evidence-based prescribing. Projects incorporate pharmacoepidemiological methods and the use of population-level linked administrative health data.
Associate Professor Rebecca McKetin: firstname.lastname@example.org
Stimulant use; methamphetamine use and harms; methamphetamine psychosis; epidemiology; in-direct prevalence estimation; sentinel surveys of substance use; cohort studies; service coverage and barriers to care.
Dr Amy Peacock: Amy.Peacock@unsw.edu.au
Trends in illicit drug use, harms, and market features; characteristics of new psychoactive substance use; drugs on the dark net; use of pharmaceutical opioids and strategies to reduce extra-medical use and harm; parental supply of alcohol and associated use and harm among young people; alcohol mortality and morbidity; alcohol-related risk-taking; data linkage.
Professor Anthony Shakeshaft: email@example.com
Intervention research, including prevention, early intervention, clinical services and policy agencies. Particular areas of interest are interventions in collaboration with Indigenous Australians and in rural/remote communities.
Dr Emily Stockings: firstname.lastname@example.org
Mental health services, policy, prevention and treatment provision; comorbid mental and physical conditions; smoking cessation; smoke-free policy; randomised controlled trials; intervention research.